Stay updated with breaking news from Nasdaq Cdmo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) Director Gregory Sargen sold 7,011 shares of the firm’s stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $20.24, for a total value of $141,902.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) General Counsel Mark R. Ziebell sold 736 shares of the firm’s stock in a transaction on Monday, April 10th. The stock was sold at an average price of $19.80, for a total value of $14,572.80. Following the completion of the transaction, the general counsel now owns 40,119 shares […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $20.74 and last traded at $20.38, with a volume of 27684 shares changing hands. The stock had previously closed at $20.27. Analysts Set New Price Targets Several equities analysts recently […]
Sargent Investment Group LLC lifted its holdings in shares of Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) by 3.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 765,096 shares of the biopharmaceutical company’s stock after acquiring an additional 22,850 shares during the period. Avid Bioservices […]
Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) CFO Daniel R. Hart sold 1,250 shares of the stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $19.00, for a total transaction of $23,750.00. Following the completion of the transaction, the chief financial officer now directly owns 46,207 shares […]